483
Serum Institute of India Pvt. Ltd.Serum Institute of India Pvt. Ltd. – FDA 483, Jan 30, 2026
Record Details
An FDA inspection of Serum Institute of India Private Ltd. in Hadapsar, Pune, revealed significant deficiencies in their vaccine manufacturing operations. The firm failed to thoroughly investigate out-of-specification results for SARS-CoV-2rS drug substance and product, and exhibited poor documentation practices for production and process controls. Additionally, equipment and utensils were not adequately cleaned and maintained, raising concerns about product contamination.
View Company Profile
ID · 229041b2-34ce-4dd6-b7b7-2ede336926cf
Other documents for Serum Institute of India Pvt. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.